Table 3.
Comparative analysis of biomarkers in chronic carriers of HBV and HDV.
| Variable | HBV |
HDV |
OR (CI 95 %) | p valuea |
|---|---|---|---|---|
| n = 50 (%) | n = 50 (%) | |||
| Age group | ||||
| ≤40 | 18 (36) | 6 (12) | 1 | |
| 41-50 | 16 (32) | 19 (38) | 3.562 (1.185–11.846) | 0.0287 |
| 51-60 | 12 (24) | 16 (32) | 4 (1.264–13.969) | 0.0223 |
| ≥60 | 4 (8) | 9 (18) | 6.750 (1.607–33.533) | 0.0124 |
| Sex | ||||
| Female | 15 (30) | 23 (46) | 0.506 (0.203–1.234) | 0.1488 |
| Male | 35 (70) | 27 (54) | ||
| Fibrosis stage | ||||
| F0/F1 | 27 (54) | 18 (36) | 1 | |
| F2/F3 | 16 (32) | 12 (24) | 1.125 (0.427–2.935) | 0.809 |
| F4 | 7 (14) | 20 (40) | 4.285 (1.557–12.902) | 0.006452 |
a
Fisher's exact test.